St. Luke's Rehabilitation Institute is a rehabilitation hospital that provides inpatient and outpatient care for children and adults in Washington state in the United States. It provides treatment for stroke, spinal cord injuries, orthopedic issues, brain injuries, other injuries and illnesses.

There are 102 beds in Saint Luke's Rehabilitation Institute.

During the past decade, Saint Luke's Rehabilitation Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's Rehabilitation Institute" #1 sponsor was "Pharnext SA" with 3 trials, followed by "Flex Pharma, Inc." with 2 trials sponsored, "St. Luke's Rehabilitation Institute" with 2 trials sponsored, "Amylyx Pharmaceuticals Inc." with 1 trials sponsored and "Gaylord Hospital, Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Rehabilitation Institute" #1 collaborator was "Washington State University" with 2 trials as a collaborator, "Medstar Health Research Institute" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator, "Spaulding Rehabilitation Hospital" with 1 trials as a collaborator and "St. Luke's Rehabilitation Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's Rehabilitation Institute" are "Charcot-Marie-Tooth Disease" (2 trials), "Stroke" (2 trials), "ALS" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Balance; Distorted" (1 trials). Many other conditions were trialed in "Saint Luke's Rehabilitation Institute" in a lesser frequency.

Most popular intervention types in "Saint Luke's Rehabilitation Institute" are "Drug" (8 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FLX-787-ODT (orally disintegrating tablet)" (2 trials), "Placebo" (2 trials), "Placebo ODT" (2 trials), "(RS)-baclofen, naltrexone hydrochloride and D-sorbitol" (1 trials) and "AMX0035" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's Rehabilitation Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Saint Luke's Rehabilitation Institute". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Saint Luke's Rehabilitation Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's Rehabilitation Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".